|
|
|
Volumn 11, Issue 5, 2001, Pages 236-237
|
|
Cost-effectiveness of HIV therapies in different economic worlds
|
|
Author keywords
Antiretroviral therapy; Developing world; Drug economics
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
NEVIRAPINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
COST EFFECTIVENESS ANALYSIS;
DEVELOPED COUNTRY;
DEVELOPING COUNTRY;
DRUG COST;
EDITORIAL;
GENOTYPE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIFE EXPECTANCY;
LYMPHOCYTE COUNT;
PATIENT COMPLIANCE;
PHENOTYPE;
QUALITY OF LIFE;
SIDE EFFECT;
TREATMENT FAILURE;
VIRUS RESISTANCE;
VIRUS TRANSMISSION;
ANTI-HIV AGENTS;
COST-BENEFIT ANALYSIS;
DEVELOPED COUNTRIES;
DEVELOPING COUNTRIES;
HIV INFECTIONS;
HUMANS;
|
|
EID: 0034974698
PISSN: 10530894
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (2)
|
|
References (10)
|
